Mental retardation: A review of the genetic causes

British Journal of Developmental Disabilities

Volumn 49, Issue 1, 2003, Pages 29-44

  Winnepenninckx, Birgitta ^a   Rooms, Liesbeth ^a   Kooy, R Frank ^a  

^a UNIVERSITY OF ANTWERP   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CHROMOSOME ABERRATION; DISABILITY; ENVIRONMENTAL FACTOR; FRAGILE X SYNDROME; HEREDITY; HUMAN; INTELLIGENCE QUOTIENT; MENTAL DEFICIENCY; METABOLIC DISORDER; PREVALENCE; REVIEW; SKILL;

EID: 0037286976     PISSN: 09697950     EISSN: None     Source Type: Journal    
DOI: 10.1179/096979503799104138     Document Type: Review

References (27)

1. Amir, R.E., Van den Veyver, I.B., Wan, M., Tran, C.Q., Francke, U. and Zoghbi, H.Y. (1999). Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nature Genetics, 23, 185-188.
2. Chelly, J. and Mandel, J.L. (2001). Monogenic causes of X-linked mental retardation. Nature Reviews Genetics, 2, 669-80.
3. Chiurazzi P., Hamel B.C.J. and Neri G. (2001). XLMR genes: update 2000. European Journal of Human Genetics, 9, 71-81.
4. Chiurazzi P., Pomponi M.G., Willemsen R., Oostra B.A. and Neri G. (1998). In vitro reactivation of the FMR1 gene involved in fragile X syndrome. Human Molecular Genetics, 7, 109-113.
5. Curry, C.J., Stevenson, R.E., Aughton, D., Byrne, J., Carey, J.C., Cassidy, S., Cunniff, C., Graham, Jr. J.M., Jones, M.C., Kaback, M.M., Moeschler, J., Schaefer, G.B., Schwartz, S., Tarleton, J. and Opitz, J. (1997). Evaluation of Mental Retardation: Recommendations of a Consensus Conference. American Journal of Medical Genetics, 72, 468-477.
6. Couvert P., Bienvenu T., Aquaviva C., Poirier K., Moraine C., Gendrot C., Verloes A., Andres C., Le Fevre A.C., Souville I., Steffann J., des Portes V., Ropers H.H., Yntema H.G., Fryns J.P., Briault S., Chelly J. and Cherif B. (2001). MECP2 is highly mutated in X-linked mental retardation, Human Molecular Genetics, 10, 941-946.
7. Croen L.A., Grether J.K. and Selvin S. (2001). The epidemiology of mental retardation of unknown cause. Pediatrics, 107, E86.
8. Duyme M., Dumaret A.-C., Tomkiewicz S. (1999). How can we boost IQs of "dull children"?: a late adoption study. Procedings of the National Academy of the United States of America, 96, 8790-8794.
9. Flint J., Wilkie A.O.M., Buckle V.J., Winter R.B., Holland A.J. and McDermid H.E. (1995). The detection of subtelomeric chromosomal rearrangements in idiopathic mental retardation. Nature Genetics, 9, 132-139.
10. Gecz J., Gedeon A.K., Sutherland G.R. and Mulley J.C. (1996) Identification of the gene FMR2, associated with FRAXE mental retardation. Nature Genetics, 13, 105-108.
11. Holinski-Feder E., Reyniers E., Uhrig S., Golla A., Wauters J., Kroisel P., Bossuyt P., Rost I., Jedele K., Zierler H., Schwab S., Wildenauer D., Speicher M., Willems P.J., Meitinger T. and Kooy R.E (2000). Familiar mental retardation syndrome ATR-16 due to an inherited cryptic subtelomeric translocation t(3;16)(q29;p13.3). America Journal of Human Genetics, 66, 16-25.
12. Hollox E.J., Atia, T., Cross, G., Parkin, T. and Armour, J.A.L (2002). High throughput screening of human subtelomeric DNA for copy number changes using mulitplex amplifiable probe hybridisation (MAPH). Journal of Medical Genetics, 39, 790-795.
13. Huber K.M., Gallagher S.M., Warren S.T. and Bear, M.E (2002). Altered synaptic plasticity in a mouse model of fragile X mental retardation. Proceedings of the National Academy of the United States of America, 99, 7746-7750.
14. Jones, C., Penny, L., Mattina, T., Yu, S., Baker, E., Voullaire, L., Langdon, W.Y., Sutherland, G.R., Richards, R.I. and Tunnacliffe, A. (1995). Association of a chromosome deletion syndrome with a fragile site within the proto-oncogene CBL2. Nature, 376, 145-9.
15. Knight, S.J.L., Regan, R., Nicod, A., Horsley, S.W., Kearney, L., Homfray, T., Winter, R.M., Bolton, P. and Flint, J. (1999). Subtle chromosomal rearrangements in children with unexplained mental retardation. Lancet, 354, 1676-1681.
16. Kooy, R. E, Williemsen, R. and Oostra, B. A. (2000). Fragile X syndrome at the turn of the century. Molecular Medicine Today, 6, 194-199.
17. Leonard, H. and Wen, X (2002). The epidemiology of mental retardation: challenges and opportunities in the new millennium. Mental Retardation and Developmental Disabilities Research Reviews, 8, 117-134.
18. Mefford H.C. and Trask B.J. (2002). The complex structure and dynamic evolution of human subtelomeres. Nature Reviews Genetics, 3, 91-102.
19. Molinari, E, Rio, M. Meskenaite, V., Encha-Razavi, F., Auge, J., Bacq, D., Briault, S., Vekemans, M., Munnich, A., Attie-Bitach, T., Sonderegger, P. and Colleaux, L. (2002). Truncating neurotrypsin mutation in autosomal recessive nonsyndromic mental retardation, Science, 298, 1779-1781.
20. Petrij, E, Giles, R. H., Dauwerse, H. G., Saris, J. J., Hennekam, R. C. M., Masuno, M.,Tommerup, N., van Ommen, G.-J. B., Goodman, R. H., Peters, D. J. M. and Breuning, M. H. (1995). Rubinstein-Taybi syndrome caused by mutations in the transcriptional co-activator CBP. Nature, 376, 348-351.
21. Plomin, R. (1999) Genetics and general cognitive ability. Nature, 402 Suppl, C25-C29.
22. Ramakers, G.J. (2002). Rho proteins, mental retardation and the cellular basis of cognition. Trends in Neurosciences, 25, 191-199.
23. Roeleveld, N., Zielhuis, G.A. and Gabreëls, E (1997). The prevalence of mental retardation: a critical review of recent literature. Developmental Medicine & Child Neurology, 39, 125-132.
24. Smeets, H. J. M., Smits, A. P. T., Verheij, C. E., Theelen, J. P. G., Willemsen, R., van de Burgt, I., Hoogeveen, A. T., Oosterwijk, J. C. and Oostra, B. A. (1995). Normal phenotype in two brothers with a full FMR1 mutation. Human Molecular Genetics, 4, 2103-2108.
25. Verkerk, A.J.M.H., Pieretti, M., Sutcliffe, J.S., Fu Y.-H., Kuhl, D.EH., Pizzuti, A., Richard, S., Victoria, M.F., Zhang, F., Eussen, B.E., van Ommen, G.-J.B., Blonden, L.A.J., Riggins, G.J., Chastain, J.L., Kunst, C.B., Galjaard, H., Caskey, C.T., Nelson, D.L., Oostra, B.A. and Warren, S.T. (1991) Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome. Cell, 65, 905-914.
26. Winnepenninckx, B., Errijgers, V., Hayez-Delatte, E, Reyniers, E. and Kooy, R.F. (2002). Identification of a family with nonspecific mental retardation (MRX79) with the A140V mutation in the MECP2 gene: Is there a need for routine screening? Human Mutation, 20, 249-52.
27. Yntema, H.G., Kleefstra, T., Oudakker, A.R., Romein, T., de Vries, B.B.A., Nillesen, W., Sistermans, E.A., Brunner, H.G., Hamel, B.C.J. and van Bokhoven, H. (2002). Low frequency of MECP2 mutations in mentally retarded males. European Journal of Human Genetics, 10, 487-490.